Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,606
Total Claims
$838K
Drug Cost
818
Beneficiaries
$1,024
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-93%
Opioid rate vs peers
0.2% vs 2.2% avg
-27%
Cost per patient vs peers
$1,024 vs $1,411 avg
+1%
Brand preference vs peers
10.7% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
15
Opioid Claims
$217
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,023 claims · $635K
Generic: 8,514 claims · $200K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 154 | $153K |
| Semaglutide | 49 | $73K |
| Empagliflozin | 35 | $52K |
| Fluticasone/Umeclidin/Vilanter | 32 | $35K |
| Mirabegron | 41 | $34K |
| Sitagliptin Phosphate | 17 | $22K |
| Fluticasone/Vilanterol | 31 | $18K |
| Rosuvastatin Calcium | 588 | $18K |
| Tirzepatide | 15 | $16K |
| Linaclotide | 12 | $15K |
| Rivaroxaban | 11 | $14K |
| Levothyroxine Sodium | 485 | $9,365 |
| Insulin Glargine,hum.Rec.Anlog | 17 | $8,892 |
| Losartan Potassium | 485 | $8,876 |
| Insulin Aspart | 31 | $8,061 |
Prescribing Profile
Patient Profile
77
Avg Age
74%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data